These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27990103)

  • 1. Two Cases of Rectal Neuroendocrine Tumor Resection Combined with Dissection of the Circular Muscle Layer Using the Endoscopic Submucosal Dissection Technique.
    Honjo K; Kure K; Ichikawa R; Ro H; Takahashi R; Niwa K; Ishiyama S; Sugimoto K; Kamiyama H; Takahashi M; Kojima Y; Goto M; Tomiki Y; Sakamoto K; Fukumura Y; Yao T
    Case Rep Gastroenterol; 2016; 10(3):693-700. PubMed ID: 27990103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resectability of Rectal Neuroendocrine Tumors Using Endoscopic Mucosal Resection with a Ligation Band Device and Endoscopic Submucosal Dissection.
    Lim HK; Lee SJ; Baek DH; Park DY; Lee BE; Park EY; Park JW; Kim GH; Song GA
    Gastroenterol Res Pract; 2019; 2019():8425157. PubMed ID: 31687016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circumferential submucosal incision prior to endoscopic mucosal resection provides comparable clinical outcomes to submucosal dissection for well-differentiated neuroendocrine tumors of the rectum.
    Cheung DY; Choi SK; Kim HK; Kim SS; Chae HS; Seo KJ; Cho YS
    Surg Endosc; 2015 Jun; 29(6):1500-5. PubMed ID: 25277474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
    Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
    Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes of endoscopic resection for rectal carcinoid tumors: an analysis of the resectability and long-term results from 46 consecutive cases.
    Kaneko H; Hirasawa K; Koh R; Kobayashi R; Kokawa A; Tanaka K; Maeda S
    Scand J Gastroenterol; 2016 Dec; 51(12):1489-1494. PubMed ID: 27687741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoloop ligation after endoscopic mucosal resection using a transparent cap: A novel method to treat small rectal carcinoid tumors.
    Zhang DG; Luo S; Xiong F; Xu ZL; Li YX; Yao J; Wang LS
    World J Gastroenterol; 2019 Mar; 25(10):1259-1265. PubMed ID: 30886508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pocket Creation Method of Endoscopic Submucosal Dissection to Ensure Curative Resection of Rectal Neuroendocrine Tumors.
    Kobori I; Katayama Y; Kitagawa T; Fujimoto Y; Oura R; Toyoda K; Kusano Y; Ban S; Tamano M
    GE Port J Gastroenterol; 2019 May; 26(3):207-211. PubMed ID: 31192290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Endoscopic Submucosal Dissection and Endoscopic Mucosal Resection Strategies for Rectal Neuroendocrine Tumors Within 20 mm.
    Yu Q; Zhang Y; Su Y; Zhao Q; Xiong K; Zhang L; Fang H
    Am Surg; 2024 Jun; 90(6):1176-1186. PubMed ID: 38192125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of endoscopic resection for rectal neuroendocrine tumors: Advantages of endoscopic submucosal resection with a ligation device compared to conventional EMR and ESD.
    Kamigaichi Y; Yamashita K; Oka S; Tamari H; Shimohara Y; Nishimura T; Inagaki K; Okamoto Y; Tanaka H; Yuge R; Urabe Y; Arihiro K; Tanaka S
    DEN Open; 2022 Apr; 2(1):e35. PubMed ID: 35310732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of endoscopic therapies for rectal neuroendocrine tumors: endoscopic submucosal dissection with myectomy versus endoscopic submucosal dissection.
    Sun P; Zheng T; Hu C; Gao T; Ding X
    Surg Endosc; 2021 Nov; 35(11):6374-6378. PubMed ID: 34231072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic submucosal dissection versus endoscopic mucosal resection for rectal carcinoid tumor. A meta-analysis and meta-regression with single-arm analysis.
    Yong JN; Lim XC; Nistala KRY; Lim LKE; Lim GEH; Quek J; Tham HY; Wong NW; Tan KK; Chong CS
    J Dig Dis; 2021 Oct; 22(10):562-571. PubMed ID: 34472210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of resectability among endoscopic treatment methods for rectal neuroendocrine tumors <10 mm.
    Toriyama K; Yamamura T; Nakamura M; Maeda K; Sawada T; Mizutani Y; Ishikawa E; Furukawa K; Ishikawa T; Ohno E; Kawashima H; Fujishiro M
    Arab J Gastroenterol; 2021 Jun; 22(2):104-110. PubMed ID: 34053887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcomes of modified endoscopic mucosal resection and endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors and the value of endoscopic morphology classification in endoscopic resection.
    Wang XY; Chai NL; Linghu EQ; Qiu ST; Li LS; Zou JL; Xiang JY; Li XX
    BMC Gastroenterol; 2020 Jun; 20(1):200. PubMed ID: 32586282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors.
    Huang JL; Gan RY; Chen ZH; Gao RY; Li DF; Wang LS; Yao J
    World J Gastrointest Surg; 2023 Mar; 15(3):440-449. PubMed ID: 37032804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic mucosal resection with a ligation device or endoscopic submucosal dissection for rectal carcinoid tumors: an analysis of 24 consecutive cases.
    Niimi K; Goto O; Fujishiro M; Kodashima S; Ono S; Mochizuki S; Asada-Hirayama I; Konno-Shimizu M; Mikami-Matsuda R; Minatsuki C; Yamamichi N; Koike K
    Dig Endosc; 2012 Nov; 24(6):443-7. PubMed ID: 23078437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of endoscopic mucosal resection using a dual-channel endoscope compared with endoscopic submucosal dissection in the treatment of rectal neuroendocrine tumors.
    Lee WH; Kim SW; Lim CH; Kim JS; Cho YK; Lee IS; Choi MG; Choi KY
    Surg Endosc; 2013 Nov; 27(11):4313-8. PubMed ID: 23807754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic submucosal dissection for treatment of rectal carcinoid tumors.
    Park HW; Byeon JS; Park YS; Yang DH; Yoon SM; Kim KJ; Ye BD; Myung SJ; Yang SK; Kim JH
    Gastrointest Endosc; 2010 Jul; 72(1):143-9. PubMed ID: 20381798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors.
    Park SB; Kim HW; Kang DH; Choi CW; Kim SJ; Nam HS
    World J Gastroenterol; 2015 Aug; 21(31):9387-93. PubMed ID: 26309365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on risk factors of positive vertical resection margin after endoscopic treatment of rectal neuroendocrine tumors].
    Wang RG; Jiang X; Ren YT; Wang J; Guo XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):643-647. PubMed ID: 31302962
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumors.
    Li W; Liu Y; Dou L; He S; Zhang Y; Ke Y; Liu X; Wang G
    J Gastrointest Oncol; 2024 Jun; 15(3):1255-1264. PubMed ID: 38989434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.